Biocryst Pharmaceuticals (BCRX) Non-Current Debt (2011 - 2026)
Biocryst Pharmaceuticals' Non-Current Debt was $395.4 million in Q2 2026, up 62.9% from $242.79 million a year earlier and up 0.1% from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Non-Current Debt (2011 - 2026) Analysis & Trends
At the end of FY2024, Non-Current Debt at Biocryst Pharmaceuticals came in at $314.87 million, up 3.8% from FY2023.
- Non-Current Debt has now increased for seven consecutive years, with a five-year compound annual growth rate of 50.1% (FY2019 to FY2024).
- In earlier years, Non-Current Debt was $303.23 million in FY2023 (+30.9%), $231.62 million in FY2022 (+70.2%), $136.08 million in FY2021 (+13.7%) and $119.74 million in FY2020 (+190.0%).
- The Q2 2026 figure marks the highest quarterly Non-Current Debt in data going back to Q2 2011.
- Compared with a year earlier, Non-Current Debt was higher in five of the last seven quarters, with growth averaging 5.6%.
- The best year-over-year quarter for Non-Current Debt over five years was Q3 2021 (growth of 391.0%); the worst was Q3 2025 (a decline of 38.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.34 Bn | 1,100.93 Bn | 19.71 Bn | 47.86 Bn |
| 2 | Johnson & Johnson | 615.91 Bn | 534.44 Bn | 17.26 Bn | 37.34 Bn |
| 3 | AbbVie | 505.47 Bn | 478.59 Bn | 12.70 Bn | 62.48 Bn |
| 4 | Merck | 368.25 Bn | 322.63 Bn | 12.21 Bn | 51.08 Bn |
| 5 | Novartis Ag | 298.18 Bn | 262.17 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 23.68 Bn |
| 7 | Amgen | 236.22 Bn | 191.62 Bn | 7.24 Bn | 51.86 Bn |
| 8 | Gilead Sciences | 190.68 Bn | 164.87 Bn | 6.22 Bn | 23.83 Bn |
| 9 | Pfizer | 170.14 Bn | 116.79 Bn | 10.94 Bn | 60.50 Bn |
| 10 | Biocryst Pharmaceuticals | 2.01 Bn | 929.26 Mn | 214.41 Mn | 395.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 395.40 Mn |
| Mar 31, 2026 | 395.20 Mn |
| Sep 30, 2025 | 194.37 Mn |
| Jun 30, 2025 | 242.79 Mn |
| Mar 31, 2025 | 315.41 Mn |
| Dec 31, 2024 | 314.87 Mn |
| Sep 30, 2024 | 314.33 Mn |
| Jun 30, 2024 | 313.82 Mn |
| Mar 31, 2024 | 308.48 Mn |
| Dec 31, 2023 | 303.23 Mn |
| Sep 30, 2023 | 298.00 Mn |
| Jun 30, 2023 | 293.18 Mn |
| Mar 31, 2023 | 232.52 Mn |
| Dec 31, 2022 | 231.62 Mn |
| Sep 30, 2022 | 223.87 Mn |
| Jun 30, 2022 | 144.52 Mn |
| Mar 31, 2022 | 140.24 Mn |
| Dec 31, 2021 | 136.08 Mn |
| Sep 30, 2021 | 132.05 Mn |
| Jun 30, 2021 | 126.80 Mn |
API Access
Biocryst Pharmaceuticals Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();